Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1.352
1.301 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1.144,5 |
-0,9%
|
$1,08 T |
|
|
|
Johnson & Johnson
JNJ
|
$258,23 |
+0,9%
|
$621,62 B |
|
|
|
Roche Holding AG
ROG
|
CHf324,9 |
+4,1%
|
$325,64 B |
|
|
|
Merck & Co Inc
MRK
|
$130,6 |
+0,6%
|
$322,56 B |
|
|
|
Novartis AG
NOVN
|
CHf126,38 |
-0,3%
|
$298,67 B |
|
|
|
AstraZeneca PLC
AZN
|
12.632 |
-0,7%
|
$264,12 B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr306,85 |
-7,3%
|
$209,50 B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$29,81 |
+12,2%
|
$155,52 B |
|
|
|
Pfizer Inc
PFE
|
$25,145 |
+0,9%
|
$143,31 B |
1.296 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita
